Stockreport

Galectin Therapeutics Highlights Belapectin Data in MASH Cirrhosis KOL Event, Eyes Next Steps [Yahoo! Finance]

Galectin Therapeutics Inc.  (GALT) 
Last galectin therapeutics inc. earnings: 11/12 08:00 am Check Earnings Report
PDF 5 million U.S. patients and no FDA-approved pharmacologic therapies — and said it is advancing regulatory discussions and seeking a partner to move belapectin forward. [Read more]